The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Episodic memory deficits are a core feature of neurodegenerative disorders. Muscarinic M1 receptors play a critical role in modulating learning and memory and are highly expressed in the hippocampus. We examined the effect of GSK1034702, a potent M1 receptor allosteric agonist, on cognitive function, and in particular episodic memory, in healthy smokers using the nicotine abstinence model of cognitive dysfunction. The study utilized a randomized, double-blind, placebo-controlled, cross-over design in which 20 male nicotine abstained smokers were tested following single doses of placebo, 4 and 8 mg GSK1034702. Compared to the baseline (nicotine on-state), nicotine abstinence showed statistical significance in reducing immediate (p=0.019) and delayed (p=0.02) recall. GSK1034702 (8 mg) significantly attenuated (i.e. improved) immediate recall (p=0.014) but not delayed recall. None of the other cognitive domains was modulated by either nicotine abstinence or GSK1034702. These findings suggest that stimulating M1 receptor mediated neurotransmission in humans with GSK1034702 improves memory encoding potentially by modulating hippocampal function. Hence, selective M1 receptor allosteric agonists may have therapeutic benefits in disorders of impaired learning including Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Two-stage model of memory trace formation: A role for “noisy” brain states
Buzsáki, G. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90423-5 · Cited by 1,709 · cited 1×
“These findings have been interpreted in the context of network models describing cholinergic function in memory processing (Buzsaki, 1989 ; Hasselmo, 1999).”
BackgroundNeuromodulation: acetylcholine and memory consolidation
Hasselmo, M. E. (1999) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(99)01365-0 · Cited by 809
Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro.
Madison, D. V., & Nicoll, R. A. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015378 · Cited by 746
Modes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
Cole, A. E., & Nicoll, R. A. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015285 · Cited by 353 · cited 1×
“Muscarinic receptor activation has also been shown to enhance hippocampal pyramidal cell spiking response to afferent input (Cole & Nicoll, 1984 ; Madison & Nicoll, 1984) and physiologically released ACh from cholinergic neurons has been shown to enhance LTP of excitatory synaptic transmission in…”
BackgroundDose-Related Enhancement of Mood and Cognition in Smokers Administered Nicotine Nasal Spray
Myers, C. S., Taylor, R. C., Moolchan, E. T., & Heishman, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301425 · Cited by 143
Cholinergic modulation of the hippocampus during encoding and retrieval
Rogers, J. L., & Kesner, R. P. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00063-7 · Cited by 141 · cited 1×
“In rodents, local infusion of scopolamine into the hippocampus has been shown to impair encoding of spatial information (Blokland et al. 1992; Rogers & Kesner, 2003).”
BackgroundPotter, P. E., Rauschkolb, P. K., Pandya, Y., Sue, L. I., Sabbagh, M. N., Walker, D. G., & Beach, T. G. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0831-1 · Cited by 94 · cited 2×
“Although not all studies have been consistent and some report a compensatory increase in M1 receptors (Overk et al. 2010), M1 receptor signal transduction-related markers or function are reportedly decreased or impaired in AD (Ferrari-DiLeo et al. 1995; Potter et al. 2011; Tsang et al. 2006, 2007).”
BackgroundResult
Cited by
The muscarinic system, cognition and schizophrenia
Carruthers, S. P., Gurvich, C. T., & Rossell, S. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.011 · Cited by 90
Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs
Hollingsworth, S. A., Kelly, B., Valant, C., Michaelis, J. A., Mastromihalis, O., Thompson, G., Venkatakrishnan, A. J., Hertig, S., Scammells, P. J., Sexton, P. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11062-7 · Cited by 73
Kurimoto, E., Matsuda, S., Shimizu, Y., Sako, Y., Mandai, T., Sugimoto, T., Sakamoto, H., & Kimura, H. (2018) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.243774 · Cited by 29
Xia, E., Xu, F., Hu, C., Kumal, J. P. P., Tang, X., Mao, D., Li, Y., Wu, D., Zhang, R., Wu, S., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.010 · Cited by 22
Theanine attenuates memory impairments induced by klotho gene depletion in mice
Nguyen, B. T., Sharma, N., Shin, E.-J., Jeong, J. H., Lee, S. H., Jang, C.-G., Nah, S.-Y., Nabeshima, T., Yoneda, Y., & Kim, H.-C. (2019) · Food & Function · doi:10.1039/c8fo01577e · Cited by 22
Metadata
- Authors
- Nathan, P. J., Watson, J., Lund, J., Davies, C. H., Peters, G., Dodds, C. M., Swirski, B., Lawrence, P., Bentley, G. D., O'Neill, B. V., Robertson, J., Watson, S., Jones, G. A., Maruff, P., Croft, R. J., Laruelle, M., & Bullmore, E. T.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-01
- Volume
- 16
- Issue
- 4
- Pages
- 721-731
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2030246304
- Cited by
- 101
- References
- 11
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. https://app.cochat.ai/papers/10.1017/s1461145712000752
- The paper
- Nathan, P. J., Watson, J., Lund, J., Davies, C. H., Peters, G., Dodds, C. M., Swirski, B., Lawrence, P., Bentley, G. D., O'Neill, B. V., Robertson, J., Watson, S., Jones, G. A., Maruff, P., Croft, R. J., Laruelle, M., & Bullmore, E. T. (2013). The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145712000752
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.